Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Data Presented At The 5th International AIDS Society Conference Suggests Low Testosterone Frequently Goes Undetected In HIV-Positive Men
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, announced that new data from the two-part HYHYHI Study (Hypogonadal Hypotestosteronism in HIV-Seropositive Men) were presented as a poster today at the 5th International AIDS Society (IAS) Conference in Cape Town, South Africa. This retrospective chart review, supported by the Company, evaluated the challenges associated with diagnosing low testosterone in men with HIV/AIDS. The study also compared the difference in testosterone levels achieved after 12 months of treatment with either Testim® 1% (testosterone gel) or AndroGel®, two commonly used FDA-approved testosterone replacement products.
generic viagra online
Another JDRF Partner Moves Research Forward With Collaboration Agreement For Diabetes Treatment
The Juvenile Diabetes Research Foundation said recently that for the fourth time in 18 months, one of its biotech partners has signed a collaboration agreement with a large pharmaceutical company to move research on type 1 diabetes into the final phases of trials.
News of the day
Medicare Revamps Competitive Bidding Program
The Centers for Medicare & Medicaid Services is preparing to revive competitive bidding program for durable medical equipment that industry members helped sink last summer when it was originally scheduled to take effect, CQ HealthBeat reports. The agency had anticipated a 26 percent savings for wheelchairs, oxygen tanks and other pieces of equipment through the program. But a lobbying group for the suppliers, the American Association for Homecare, successfully urged Congress to shut down the program before it went into effect.
Oncology

Kai Sensors Receives FDA Clearance For Its Wireless, Non-Contact Respiratory Device

Hawaii-based Kai Sensors announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Kai Sensors Non-Contact Respiratory Rate Spot Check, also called the Kai RSpot. The 510(k) clearance allows Kai Sensors to market the Kai RSpot to physicians, hospitals, and clinics. The Kai RSpot is a device that offers a practical and effective approach of measuring respiratory rate in hospital and clinical settings. The device is easy to use and works wirelessly, with no contact or attachment to the patient. Due to difficulties with current approaches of measuring respiratory rate, this important vital sign is often measured infrequently, inaccurately, inconsistently, or not at all. The clinically tested Kai RSpot provides a solution that addresses many of the shortcomings of existing technologies, and will enable doctors and health care professionals to measure a patient"s respiration with greater ease and with increased regularity. "The 510(k) approval from the FDA is a major milestone for Kai Sensors that will enable our Company to continue to grow," said Kai Sensors CEO Andrea Yuen. "We believe the Kai RSpot will make collecting respiratory information easier for physicians and clinicians and thus help increase the amount of information available about a patient and improve the overall quality of health care." Kai Sensors, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009